Skip Navigation


Carcinogenesis Advance Access originally published online on July 17, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/10/1677    most recent
bgg120v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jeon, H.-S.
Right arrow Articles by Park, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeon, H.-S.
Right arrow Articles by Park, J. Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 10, 1677-1681, October 2003
© 2003 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer

Hyo-Sung Jeon1, Kyung Mee Kim2, Sun Ha Park1, Su Yeon Lee1, Jin Eun Choi1, Ga Young Lee2, Sin Kam3, Rang Woon Park2, In-San Kim2, Chang Ho Kim4, Tae Hoon Jung4 and Jae Yong Park1,2,4,5

1 Cancer Research Institute, 2 Department of Biochemistry and 3 Department of Preventive Medicine, School of Medicine, Kyungpook National University, Dong In 2 Ga 101, Daegu, 700-422, Korea and 4 Department of Internal Medicine, Kyungpook National University Hospital, Samduk 2ga 50, Daegu, 700-412, Korea

DNA repair plays a critical role in protecting the genome from insults of cancer-causing agents, such as those found in tobacco smoke. Therefore, reduced DNA repair capacity can increase the susceptibility to smoking-related cancers. Recently, several polymorphisms have been identified in the xeroderma pigmentosum group G (XPG) gene, and it is possible that these polymorphisms may affect the DNA repair capacity, thereby modulating cancer susceptibility. We investigated the relationship between the His1104Asp polymorphism in the XPG gene and the risk of lung cancer. The study population consisted of 310 lung cancer patients and 311 healthy controls who were frequency (1:1) matched based on age and sex. The Asp/Asp genotype was more frequent in the controls (28.9%) than in the cases (18.7%) and associated with a significantly decreased risk of lung cancer [adjusted odds ratio (OR) = 0.54, 95% confidence interval (CI) = 0.37–0.80] when the combined His/His and His/Asp genotype was used as the reference. The protective effect of the Asp/Asp genotype against lung cancer was statistically significant in the older subjects (adjusted OR = 0.51, 95% CI = 0.37–0.80), males (adjusted OR = 0.54, 95% CI = 0.35–0.83), and lighter smokers (adjusted OR = 0.48, 95% CI = 0.25–0.94) in a stratification analysis. When the lung cancers were analyzed by histologic type, the Asp/Asp genotype was associated with a significantly decreased risk of squamous cell carcinoma (adjusted OR = 0.55, 95% CI = 0.34–0.88) and small cell lung cancer (adjusted OR = 0.44, 95% CI = 0.20–0.97), but non-significant decreased risk of adenocarcinoma (adjusted OR = 0.64, 95% CI = 0.36–1.12). These results suggest that the XPG codon 1104 polymorphism contributes to genetic susceptibility to lung cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Acta Biochim Biophys SinHome page
J. Feng, X. Sun, N. Sun, S. Qin, F. Li, H. Cheng, B. Chen, Y. Cao, J. Ma, L. Cheng, et al.
XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer
Acta Biochim Biophys Sin, May 1, 2009; 41(5): 429 - 435.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
K. F. NARTER, A. ERGEN, B. AGACHAN, U. GORMUS, O. TIMIRCI, and T. ISBIR
Bladder Cancer and Polymorphisms of DNA Repair Genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1)
Anticancer Res, April 1, 2009; 29(4): 1389 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E.L. Crawford, T. Blomquist, D.N. Mullins, Y. Yoon, D.R. Hernandez, M. Al-Bagdhadi, J. Ruiz, J. Hammersley, and J.C. Willey
CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions
Carcinogenesis, December 1, 2007; 28(12): 2552 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L.-E Wang, C. Li, S. S. Strom, L. H. Goldberg, A. Brewster, Z. Guo, Y. Qiao, G. L. Clayman, J. J. Lee, A. K. El-Naggar, et al.
Repair Capacity for UV Light Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression
Clin. Cancer Res., November 1, 2007; 13(21): 6532 - 6539.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al.
Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. An, Z. Liu, Z. Hu, G. Li, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, M. R. Spitz, and Q. Wei
Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1633 - 1638.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Michiels, P. Danoy, P. Dessen, A. Bera, T. Boulet, C. Bouchardy, M. Lathrop, A. Sarasin, and S. Benhamou
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
Carcinogenesis, August 1, 2007; 28(8): 1731 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Li, Z. Hu, Z. Liu, L.-E Wang, S. S. Strom, J. E. Gershenwald, J. E. Lee, M. I. Ross, P. F. Mansfield, J. N. Cormier, et al.
Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2526 - 2532.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku
Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study
Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Garcia-Closas, N. Malats, F. X. Real, R. Welch, M. Kogevinas, N. Chatterjee, R. Pfeiffer, D. Silverman, M. Dosemeci, A. Tardon, et al.
Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian, and A. Haugen
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
Carcinogenesis, March 1, 2006; 27(3): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter
DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Lee, S. Y. Lee, H.-S. Jeon, S. H. Park, J. S. Jang, G. Y. Lee, J. W. Son, C. H. Kim, W. K. Lee, S. Kam, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 571 - 575.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. J. Lee, H.-S. Jeon, J.-S. Jang, S. H. Park, G. Y. Lee, B.-H. Lee, C. H. Kim, Y. M. Kang, W. K. Lee, S. Kam, et al.
DNMT3B polymorphisms and risk of primary lung cancer
Carcinogenesis, February 1, 2005; 26(2): 403 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Hagmar, U. Stromberg, S. Bonassi, I.-L. Hansteen, L. E. Knudsen, C. Lindholm, and H. Norppa
Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk: Results from Nordic and Italian Cohorts
Cancer Res., March 15, 2004; 64(6): 2258 - 2263.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.